| # | Drug | Count |
|---|---|---|
| 0 | ENZALUTAMIDE | 13 |
| 1 | LEUPROLIDE ACETATE | 13 |
| 2 | BICALUTAMIDE | 12 |
| 3 | OXALIPLATIN | 6 |
| 4 | RUXOLITINIB | 6 |
| 5 | PREGABALIN | 4 |
| 6 | RITUXIMAB | 4 |
| 7 | CARBOPLATIN | 3 |
| 8 | CYCLOPHOSPHAMIDE | 3 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRILOCAINE HYDROCHLORIDE | 1 | 0.0062 |
| 1 | PEMIGATINIB | 1 | 0.0012 |
| 2 | BICALUTAMIDE | 12 | 0.0008 |
| 3 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 4 | DAPRODUSTAT | 1 | 0.0005 |
| 5 | MARIBAVIR | 1 | 0.0004 |
| 6 | DECITABINE | 1 | 0.0002 |
| 7 | ENZALUTAMIDE | 13 | 0.0002 |
| 8 | OXYMETAZOLINE HYDROCHLORIDE | 1 | 0.0002 |
| 9 | LEUPROLIDE ACETATE | 13 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Androgen Receptor Inhibitor [EPC] | 13 |
| 1 | Janus Kinase Inhibitor [EPC] | 8 |
| 2 | Kinase Inhibitor [EPC] | 7 |
| 3 | Platinum-based Drug [EPC] | 7 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 4 |
| 5 | Corticosteroid [EPC] | 4 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 4 |
| 7 | Alkylating Drug [EPC] | 3 |
| 8 | BCL-2 Inhibitor [EPC] | 2 |
| 9 | Benzodiazepine [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Androgen Receptor Inhibitor [EPC] | 13 | 0.0002 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 4 | Janus Kinase Inhibitor [EPC] | 8 | 0.0000 |
| 5 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 6 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | BCL-2 Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Rifamycin Antibacterial [EPC] | 1 | 0.0000 |